Simulations Plus (NASDAQ:SLP) CFO John Robert Kneisel sold 2,991 shares of the firm’s stock in a transaction dated Friday, April 20th. The stock was sold at an average price of $17.64, for a total value of $52,761.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Simulations Plus stock traded down $0.20 during trading hours on Monday, reaching $17.65. The stock had a trading volume of 45,267 shares, compared to its average volume of 54,332. The company has a market cap of $309.27, a price-to-earnings ratio of 51.91 and a beta of -0.56. Simulations Plus has a 1 year low of $11.00 and a 1 year high of $18.00.
Simulations Plus (NASDAQ:SLP) last announced its earnings results on Monday, April 9th. The technology company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. The business had revenue of $7.36 million for the quarter, compared to the consensus estimate of $7.37 million. Simulations Plus had a return on equity of 26.19% and a net margin of 30.65%. analysts expect that Simulations Plus will post 0.4 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 2nd. Investors of record on Wednesday, April 25th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Tuesday, April 24th. This represents a $0.24 annualized dividend and a dividend yield of 1.36%. Simulations Plus’s payout ratio is currently 70.59%.
Several large investors have recently made changes to their positions in SLP. Bank of Montreal Can purchased a new stake in shares of Simulations Plus during the 4th quarter valued at about $104,000. The Manufacturers Life Insurance Company raised its holdings in shares of Simulations Plus by 13.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock valued at $110,000 after buying an additional 1,085 shares during the period. Strs Ohio raised its holdings in shares of Simulations Plus by 196.9% during the 4th quarter. Strs Ohio now owns 9,500 shares of the technology company’s stock valued at $152,000 after buying an additional 6,300 shares during the period. Algert Global LLC purchased a new stake in shares of Simulations Plus during the 4th quarter valued at about $175,000. Finally, California State Teachers Retirement System purchased a new stake in shares of Simulations Plus during the 2nd quarter valued at about $240,000. Institutional investors and hedge funds own 33.63% of the company’s stock.
A number of equities analysts have recently commented on the company. BidaskClub upgraded Simulations Plus from a “sell” rating to a “hold” rating in a report on Saturday, April 7th. ValuEngine upgraded Simulations Plus from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research downgraded Simulations Plus from a “buy” rating to a “hold” rating in a report on Friday, March 23rd.
COPYRIGHT VIOLATION WARNING: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/23/insider-selling-simulations-plus-slp-cfo-sells-2991-shares-of-stock.html.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.